Company intelligence / Profile preview

The Riva Bio

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Riva Therapeutics is a precision oncology company focused on developing next-generation therapies for cancer patients with limited treatment options. The company leverages a proprietary platform to identify and target specific molecular vulnerabilities in tumors, aiming to create highly selective small molecule inhibitors. Riva's approach integrates advanced computational biology with deep expertise in medicinal chemistry to accelerate the discovery of novel drug candidates. Currently in the pre-clinical stage, the company is building a pipeline of programs designed to overcome resistance mechanisms in various solid tumors.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on The Riva Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Riva Bio.

Explore the full profile